BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6877481)

  • 1. [Anomalies of human gonadal function in periodic hemodialysis: role of the etiology of kidney failure and the role of iron overload].
    Dueymes JM; Caron P; Pourrat JP; Louvet JP; Conté JJ
    Nephrologie; 1983; 4(2):69-74. PubMed ID: 6877481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of many years of hemodialysis therapy on hypophyseal-gonadal axis function in males with chronic renal insufficiency].
    Starzyk J; Grzeszczak W
    Pol Tyg Lek; 1996 Feb; 51(6-9):79-81. PubMed ID: 8756737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gynecomastia and chronic renal insufficiency in periodic hemodialysis. Demonstration of a decrease in the free fraction of testosterone].
    Caron P; Dueymes JM; Pourrat J; Conte JJ; Louvet JP
    Rev Med Interne; 1984 Jun; 5(2):110-3. PubMed ID: 6473955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of anemia in 86 patients on hemodialysis (author's transl)].
    Serra A; Camps J; Morlans M; Olmos A; Carrera A; Soriano B; Rodríguez JA; Pelegrí A; Bartolomé J; Piera L
    Med Clin (Barc); 1981 May; 76(10):439-43. PubMed ID: 7242164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sexual dysfunction among 78 Moroccan male hemodialysis patients: clinical and endocrine study].
    Zamd M; Farh M; Hbid O; Zabari M; Benghanem Gharbi M; Ramdani B; Zaïd D; El Abbadi N; Lalaoui K; Belhouari A; Hassan Tahri E
    Ann Endocrinol (Paris); 2004 May; 65(3):194-200. PubMed ID: 15277975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL.
    Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Grapsa EI; Passalidou IA; Tziamalis MP; Poulakou MV; Vlachos IS; Perrea DN
    Hemodial Int; 2008 Jan; 12(1):100-7. PubMed ID: 18271850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecomastia during hemodialysis.
    Can Med Assoc J; 1969 Feb; 100(8):394-5. PubMed ID: 5765409
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of many years of hemodialysis therapy on FSH secretion induced by luliberin in men with chronic renal failure].
    Starzyk J; Grzeszczak W; Kowalski D
    Wiad Lek; 1993 Apr; 46(7-8):286-91. PubMed ID: 8249417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine abnormalities in hemodialysis patients with iron overload: reversal with iron depletion.
    el-Reshaid K; Seshadri MS; Hourani H; Qurtom M; Kamel H
    Nutrition; 1995; 11(5 Suppl):521-6. PubMed ID: 8748213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine changes and sexual dysfunction in kidney transplantation and hemodialysis: comparative study].
    Rodríguez Rodríguez R; Burgos Revilla FJ; Gómez Dosantos V; Galbis Sanjuan F; Navarro Antolín J; Allona Almagro A; Orofino Azcue L
    Actas Urol Esp; 1996 Sep; 20(8):697-701. PubMed ID: 9019943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
    Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
    J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options.
    Iglesias P; Carrero JJ; Díez JJ
    J Nephrol; 2012; 25(1):31-42. PubMed ID: 21748720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum ferritin and iron therapy in patients treated with periodic hemodialysis].
    Docci D; Cenciotti L; Turci F; Salvi G; Mosconi G; Baldrati L
    Quad Sclavo Diagn; 1982 Dec; 18(4):454-62. PubMed ID: 7186648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
    Fishbane S
    Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypogonadism, a serious complication of chronic renal insufficiency].
    Zofková I; Bubenícek P; Sotorník I
    Vnitr Lek; 2007 Jun; 53(6):709-14. PubMed ID: 17702131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.